Provided by Tiger Trade Technology Pte. Ltd.

Arbutus Biopharma

5.20
0.0000
Post-market: 5.18-0.0200-0.38%19:30 EDT
Volume:8.91M
Turnover:46.29M
Market Cap:1.02B
PE:6.59
High:5.26
Open:5.25
Low:5.13
Close:5.20
52wk High:5.45
52wk Low:3.50
Shares:196.94M
Float Shares:123.00M
Volume Ratio:1.05
T/O Rate:7.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7896
EPS(LYR):-0.1748
ROE:89.58%
ROA:48.84%
PB:3.96
PE(LYR):-29.74

Loading ...

Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Aug 12

Arbutus Biopharma Corp Expected to Post a Loss of 2 Cents a Share - Earnings Preview

Reuters
·
Jul 31

Arbutus Biopharma Reshapes Strategy After Moderna Settlement

TIPRANKS
·
Jul 17

Arbutus Biopharma, Genevant sue Pfizer, BioNTech Over Lipid Nanoparticle Patents

MT Newswires Live
·
Jul 16

Arbutus Files Patent Infringement Suits Against Pfizer, Biontech over LNP Technology

Reuters
·
Jul 16

Arbutus Biopharma Corp - Anticipates Receipt of Dividend from Genevant in Q3 2026

THOMSON REUTERS
·
Jul 16

Arbutus Biopharma Corp - Co and Genevant File Lawsuit in Canada Seeking Injunction and Damages Against Pfizer/biontech

THOMSON REUTERS
·
Jul 16

Arbutus Biopharma Corp - Expects to Return up to $230 Mln in Capital to Shareholders

THOMSON REUTERS
·
Jul 16

Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and Biontech, Receives First Payment from Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders

THOMSON REUTERS
·
Jul 16

Arbutus Biopharma Corp - Receives About $178 Mln from Moderna Under March 2026 Settlement Agreement

THOMSON REUTERS
·
Jul 16

Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders

GlobeNewswire
·
Jul 16

Arbutus Biopharma Shareholders Approve New 2026 Incentive Plan

TIPRANKS
·
May 28

Arbutus Biopharma shareholders approve 2026 omnibus share, incentive plan at annual meeting

Reuters
·
May 28

Arbutus Biopharma Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Arbutus Biopharma Swings to Profit in Q1, Revenue Rises; Shares Up Pre-Bell

MT Newswires Live
·
May 13

Arbutus Biopharma Q1 EPS $0.87 Beats $(0.04) Estimate, Sales $179.126M Beat $750.000K Estimate

Benzinga Earnings
·
May 13

Arbutus Biopharma Q1 revenue surges on Moderna settlement

Reuters
·
May 13

Arbutus Biopharma Q1 Revenue USD 179.1 Million

THOMSON REUTERS
·
May 13

Arbutus Biopharma Q1 EPS USD 0.87

THOMSON REUTERS
·
May 13

Earnings Flash (ABUS) Arbutus Biopharma Posts Q1 EPS $0.87, vs. FactSet Est of $0.03 Loss

MT Newswires Live
·
May 13